Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DDX10P2, or DEAD-box helicase 10 pseudogene 2, is a pseudogene. Pseudogenes are sequences in the genome that resemble known genes but are generally not functional—they do not encode an active protein product. This particular gene is classified as a pseudogene of the DEAD-box helicase 10 (DDX10) gene, which itself encodes an RNA helicase involved in various aspects of RNA metabolism, such as ribosome assembly, translation initiation, and RNA splicing[3][5]. However, DDX10P2 does not encode a functional protein, is not known to be involved in any biological functions or disease processes, and is not considered a drug target or a biomarker. There are no known drugs or therapeutic interventions directed at DDX10P2[3][5]. Key points: - DDX10P2 is a pseudogene, meaning it is a non-functional, non-coding genomic element. - The functional analog, DEAD-box helicase 10 (DDX10), participates in RNA metabolism and has roles in innate immunity and possibly in several diseases, but DDX10P2 itself does not[3][5]. - There is no evidence from reference databases or scientific literature that DDX10P2 encodes a targetable protein, participates in disease pathways, or interacts with known drugs. - If a functional DEAD-box helicase is required for study or targeting, the correct entry should be “DEAD-box helicase 10 (DDX10)” and not DDX10P2[3][5]. Summary of issue: - DDX10P2 is a pseudogene, not a protein-coding or functional therapeutic target. There is no evidence to suggest it encodes a protein or acts as a molecular target in pharmacology or disease biology. If this was intended to describe an active RNA helicase, the correct entry would be DEAD-box helicase 10 (DDX10), not DDX10P2. Note: If structured information is needed about a functional DEAD-box helicase target, data for DEAD-box helicase 10 (DDX10) should be used instead, as DDX10P2 is not biologically active[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DEAD-box helicase 10 pseudogene 2 (DDX10P2).